Literature DB >> 31204788

Paecilomyces/Purpureocillium keratitis: A consecutive study with a case series and literature review.

Yen-Ting Chen1, Lung-Kun Yeh1,2, David H K Ma1,2, Hsin-Chiung Lin1,2, Chi-Chin Sun2,3, Hsin-Yuan Tan1,2, Hung-Chi Chen1,2, Shin-Yi Chen2,3, Pei-Lun Sun2,4, Ching-Hsi Hsiao1,2.   

Abstract

Paecilomyces/Purpureocillium species is an emerging pathogen of fungal keratitis; the risk factor, clinical course, and outcome of Paecilomyces/Purpureocillium keratitis need more exploration. We retrospectively reviewed 12 patients with culture-proven Paecilomyces/Purpureocillium keratitis in our hospital from 2003 to 2017 and combined them with 50 previous cases reported after the review conducted by Yuan et al. in 2009. Clinical features between the previously and newly reported cases were compared using the publication by Yuan et al. as a cutoff point. The mean age of the 62 newly reported patients with Paecilomyces/Purpureocillium keratitis was 52.7 years. Of these, contact lens wear was the most common predisposing factor (n = 32, 52%), followed by a preexisting corneal disease or previous ocular surgery (n = 12, 19%), and trauma (n = 8, 13%). Fifty eyes (81%) were treated with voriconazole, of which 31 (63%) were medically cured. Twenty-one of 62 eyes (34%) required therapeutic surgery. Compared with the 42 patients reported by Yuan et al., the patients were younger (P = .025); a higher proportion of the patients were contact lens wearers (P = .005); more patients were treated with voriconazole (P = .000); fewer patients required therapeutic surgery (P = .000) in recent reports. Contact lens use has become the major risk factor for Paecilomyces/Purpureocillium keratitis. The surgical rate has been significantly lower in recent publications, probably because of the prevalent use of voriconazole.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  zzm321990 Paecilomyces/Purpureocilliumzzm321990 ; keratitis; voriconazole

Year:  2020        PMID: 31204788     DOI: 10.1093/mmy/myz059

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  5 in total

1.  Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.

Authors:  Rosanne Sprute; Jon Salmanton-García; Ertan Sal; Xhorxha Malaj; Zdeněk Ráčil; Carlos Ruiz de Alegría Puig; Iker Falces-Romero; Aleksandra Barać; Guillaume Desoubeaux; Anupma Jyoti Kindo; Arthur J Morris; René Pelletier; Joerg Steinmann; George R Thompson; Oliver A Cornely; Danila Seidel; Jannik Stemler
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790

2.  Species Identification and In Vitro Antifungal Susceptibility of Paecilomyces/Purpureocillium Species Isolated from Clinical Respiratory Samples: A Multicenter Study.

Authors:  Lorra Monpierre; Nawel Aït-Ammar; Isabel Valsecchi; Anne-Cécile Normand; Juliette Guitard; Arnaud Riat; Antoine Huguenin; Christine Bonnal; Boualem Sendid; Lilia Hasseine; Hélène Raberin; Marion Dehais; Stéphane Ranque; Christophe Hennequin; Renaud Piarroux; Eric Dannaoui; Françoise Botterel
Journal:  J Fungi (Basel)       Date:  2022-06-29

3.  Paecilomyces/Purpureocillium Infection in Children, Case Report, and Review of the Literature.

Authors:  Musaed Alharbi; Nourah Alruqaie; Ahmed Alzahrani; Maha Almuneef
Journal:  J Fungi (Basel)       Date:  2022-09-01

4.  Filamentous Fungal Keratitis in Taiwan: Based on Molecular Diagnosis.

Authors:  Ning Hung; Lung-Kun Yeh; David Hui-Kang Ma; Hsin-Chiung Lin; Hsin-Yuan Tan; Hung-Chi Chen; Pei-Lun Sun; Ching-Hsi Hsiao
Journal:  Transl Vis Sci Technol       Date:  2020-07-21       Impact factor: 3.283

5.  Eye Infections Caused by Filamentous Fungi: Spectrum and Antifungal Susceptibility of the Prevailing Agents in Germany.

Authors:  Grit Walther; Anna Zimmermann; Johanna Theuersbacher; Kerstin Kaerger; Marie von Lilienfeld-Toal; Mathias Roth; Daniel Kampik; Gerd Geerling; Oliver Kurzai
Journal:  J Fungi (Basel)       Date:  2021-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.